Fátima Regina Mena Barreto Silva Selected Research

Hypoxia (Hypoxemia)

1/2016

In vivo inhibition of tumor progression by 5 hydroxy-1,4-naphthoquinone (juglone) and 2-(4-hydroxyanilino)-1,4-naphthoquinone (Q7) in combination with ascorbate.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fátima Regina Mena Barreto Silva Research Topics

Disease

2	Congenital Hypothyroidism (Cretinism) 12/2018 - 01/2018
1	Hyperglycemia 09/2021
1	Cysts 02/2021
1	Insulin Resistance 01/2021
1	Hypothyroidism 12/2018
1	Hypoxia (Hypoxemia) 01/2016
1	Neoplasms (Cancer) 01/2016
1	Type 2 Diabetes Mellitus (MODY) 10/2014

Drug/Important Bio-Agent (IBA)

2	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2016
2	EnzymesIBA 12/2018 - 01/2016
1	Liver GlycogenIBA 09/2021
1	Insulin (Novolin)FDA Link 09/2021
1	pyriproxyfenIBA 02/2021
1	Thyroid HormonesIBA 12/2018
1	Cholinergic Agents (Cholinergics)IBA 12/2018
1	Drinking WaterIBA 01/2018
1	Propylthiouracil FDA Link 01/2018
1	Reverse TriiodothyronineIBA 01/2018
1	Ethidium (Ethidium Bromide)IBA 01/2016
1	AntioxidantsIBA 01/2016
1	Adenosine Diphosphate (ADP)IBA 01/2016
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2016
1	Cyclin AIBA 01/2016
1	Proteins (Proteins, Gene)FDA Link 01/2016
1	Acridine OrangeIBA 01/2016
1	jugloneIBA 01/2016
1	2-(4-hydroxyanilino)-1,4-naphthoquinoneIBA 01/2016
1	Glyburide (Glibenclamide)FDA LinkGeneric 10/2014

Therapy/Procedure

1	Therapeutics 10/2014